
### [NCIT:C43372](http://purl.obolibrary.org/obo/NCIT_C43372)
**Label:** Lentigo Maligna

**Subclasses:** 

**Class expressions from DL-Learner:**

- Thing 53.30%
- [NCIT:C90530](http://purl.obolibrary.org/obo/NCIT_C90530) (AJCC v7 Stage) 52.94%
- [NCIT:C90529](http://purl.obolibrary.org/obo/NCIT_C90529) (AJCC v6 Stage) 52.94%
- [NCIT:C28051](http://purl.obolibrary.org/obo/NCIT_C28051) (Stage 0) and (not ([NCIT:C27965](http://purl.obolibrary.org/obo/NCIT_C27965) (Stage 0is))) 38.30%
- [NCIT:C28051](http://purl.obolibrary.org/obo/NCIT_C28051) (Stage 0) and (not ([NCIT:C27964](http://purl.obolibrary.org/obo/NCIT_C27964) (Stage 0a))) 38.30%
- [NCIT:C28108](http://purl.obolibrary.org/obo/NCIT_C28108) (Disease Stage Qualifier) 33.82%
- [NCIT:C28051](http://purl.obolibrary.org/obo/NCIT_C28051) (Stage 0) 31.81%
- [NCIT:C28051](http://purl.obolibrary.org/obo/NCIT_C28051) (Stage 0) and (not ([NCIT:C40163](http://purl.obolibrary.org/obo/NCIT_C40163) (Uterine Corpus Cellular Leiomyoma))) 31.81%
- [NCIT:C28051](http://purl.obolibrary.org/obo/NCIT_C28051) (Stage 0) and (not ([NCIT:C40162](http://purl.obolibrary.org/obo/NCIT_C40162) (Uterine Corpus Leiomyoma, Mitotically Active Variant))) 31.81%
- [NCIT:C28051](http://purl.obolibrary.org/obo/NCIT_C28051) (Stage 0) and (not ([NCIT:C40161](http://purl.obolibrary.org/obo/NCIT_C40161) (JAZF1-SUZ12 Fusion Protein Expression))) 31.81%
- [NCIT:C28051](http://purl.obolibrary.org/obo/NCIT_C28051) (Stage 0) and (not ([NCIT:C40160](http://purl.obolibrary.org/obo/NCIT_C40160) (t(7;17)(p15;q21)))) 31.81%
- [NCIT:C28051](http://purl.obolibrary.org/obo/NCIT_C28051) (Stage 0) and (not ([NCIT:C40156](http://purl.obolibrary.org/obo/NCIT_C40156) (Endometrial Undifferentiated Carcinoma))) 31.81%
- [NCIT:C28051](http://purl.obolibrary.org/obo/NCIT_C28051) (Stage 0) and (not ([NCIT:C40155](http://purl.obolibrary.org/obo/NCIT_C40155) (Endometrial Small Cell Carcinoma))) 31.81%
- [NCIT:C28051](http://purl.obolibrary.org/obo/NCIT_C28051) (Stage 0) and (not ([NCIT:C40154](http://purl.obolibrary.org/obo/NCIT_C40154) (Endometrial Transitional Cell Carcinoma))) 31.81%
- [NCIT:C28051](http://purl.obolibrary.org/obo/NCIT_C28051) (Stage 0) and (not ([NCIT:C40153](http://purl.obolibrary.org/obo/NCIT_C40153) (Endometrial Mixed Adenocarcinoma))) 31.81%


